You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Other Hematologic Malignancies

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non-hodgkin's Lymphoma Trial in Beijing (GNC-035)

Not yet recruiting
  • Non-hodgkin's Lymphoma
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Sep 27, 2023

Advanced Systemic Mastocytosis Trial (BLU-263, Azacitidine)

Not yet recruiting
  • Advanced Systemic Mastocytosis
  • (no location specified)
Nov 2, 2022

Multiple Myeloma Trial in Worldwide (GEN3014 (HexaBody®-CD38))

Recruiting
  • Multiple Myeloma
  • +2 more
  • Atlanta, Georgia
  • +19 more
Dec 12, 2022

Relapsed/Refractory Chronic Lymphocytic Leukemia Trial in Tianjin (GNC-035)

Not yet recruiting
  • Relapsed/Refractory Chronic Lymphocytic Leukemia
  • Tianjin, Tianjin, China
    Institute of Hematology and Blood Diseases Hospital, Chinese Aca
Jul 13, 2023

Hematologic Malignancies Trial in Baltimore (drug, radiation, procedure)

Recruiting
  • Hematologic Malignancies
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Feb 14, 2022

Leukemia, Acute Myeloid Leukemia in Remission, Myelodysplasia Trial (Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi))

Not yet recruiting
  • Leukemia
  • +12 more
  • Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi)
  • (no location specified)
Mar 20, 2023

Optical Genome Mapping in Hematological Malignancies

Recruiting
  • MDS
  • +2 more
    • Brest, France
    • +3 more
    Aug 16, 2021

    Relapsed or Refractory Acute Myeloid Leukemia (AML), Untreated AML, Other IDH1-mutated Positive Hematologic Malignancies Trial

    Recruiting
    • Relapsed or Refractory Acute Myeloid Leukemia (AML)
    • +3 more
    • Birmingham, Alabama
    • +26 more
    Sep 12, 2022

    Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

    Recruiting
    • Myelodysplastic Syndrome (MDS)
    • +3 more
    • Cord Blood Transplant
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Sep 22, 2021

    Hematologic Malignancies Trial in Assiut (CD56)

    Recruiting
    • Hematologic Malignancies
    • CD56
    • Assiut, Egypt
    • +1 more
    Jul 20, 2022

    Chronic Lymphocytic Leukemia (CLL), Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL) Trial (Routine care as per

    Not yet recruiting
    • Chronic Lymphocytic Leukemia (CLL)
    • +5 more
    • Routine care as per site standard.
    • (no location specified)
    Sep 15, 2023

    Relmacabtagene Autoleucel in Hematologic Malignancies

    Not yet recruiting
    • Lymphoma, B-Cell
    • +2 more
    • Relmacabtagene Autoleucel
    • Beijing, Beijing, China
    • +1 more
    Nov 15, 2023

    Hematologic Malignancy, Hematologic Tumors, Hematologic Diseases Trial in Nanjing, Suzhou, Tianjin (Flow Cytometry)

    Not yet recruiting
    • Hematologic Malignancy
    • +2 more
    • Flow Cytometry
    • Nanjing, Jiangsu, China
    • +2 more
    Apr 17, 2023

    Hematologic Tumors, Neutropenia, Anemia Trial in Wuhan (umbilical cord derived mesenchymal stem cells)

    Not yet recruiting
    • Hematologic Neoplasms
    • +5 more
    • umbilical cord derived mesenchymal stem cells
    • Wuhan, Hubei, China
    • +2 more
    Jan 3, 2023

    Acute Lymphoblastic Leukemia, B-cell Lymphoma, Chronic Lymphocytic Leukemia Trial in Xuzhou (allogenic CD19-CAR-NK cells)

    Recruiting
    • Acute Lymphoblastic Leukemia
    • +2 more
    • allogenic CD19-CAR-NK cells
    • Xuzhou, Jiangsu, China
      The Affiliated Hospital of Xuzhou Medical University
    Feb 11, 2023

    Adult Relapsed/Refractory B-cell Hematologic Malignancies Trial in Beijing (CD19-CAR-NK)

    Recruiting
    • Adult Relapsed/Refractory B-cell Hematologic Malignancies
    • CD19-CAR-NK
    • Beijing, Beijing, China
      The Fifth Medical Center of Chinese People's Liberation Army (PL
    Dec 1, 2022

    B-Cell Lymphoblastic Leukemia/Lymphoma Trial in Kunming (Anti-CD19 UCAR-NK cells)

    Recruiting
    • B-Cell Lymphoblastic Leukemia/Lymphoma
    • Anti-CD19 UCAR-NK cells
    • Kunming, Yunnan, China
      920th Hospital of Joint Logistics Support Force of People's Libe
    Dec 19, 2022

    Acute Myeloid Leukemia, B-cell Acute Lymphoblastic Leukemia, High-risk Myelodysplastic Syndrome Trial (VIP943)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • +2 more
    • (no location specified)
    Sep 5, 2023

    B-cell Lymphoma, B-cell Leukemia Trial in Kunming (anti-CD19 UCAR-NK cells)

    Withdrawn
    • B-cell Lymphoma
    • B-cell Leukemia
    • anti-CD19 UCAR-NK cells
    • Kunming, Yunnan, China
      Kunming Hope of Health Hospital
    Nov 27, 2022

    Acute GVHD, Hematopoietic and Lymphoid System Tumor Trial in Duarte (Cholestyramine, Leflunomide, Steroid Therapy)

    Recruiting
    • Acute Graft Versus Host Disease
    • Hematopoietic and Lymphoid System Neoplasm
    • Duarte, California
      City of Hope Medical Center
    Jan 5, 2023

    Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in New York (radiation, drug,

    Completed
    • Acute Lymphoblastic Leukemia
    • +3 more
    • total body irradiation
    • +7 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    May 17, 2021

    Hematologic Malignancy, Blood Cancer, Lymphoma Trial in Boston (Palliative Care, Usual Care)

    Recruiting
    • Hematologic Malignancy
    • +4 more
    • Palliative Care
    • Usual Care
    • Boston, Massachusetts
      Massachusetts General Hospital Cancer Center
    Jan 24, 2023

    Hematologic Malignancies Trial in Zhengzhou (RD13-02 cell infusion)

    Recruiting
    • Hematologic Malignancies
    • RD13-02 cell infusion
    • Zhengzhou, Henan, China
      Henan Cancer Hospital
    Jun 26, 2023

    Hematologic Malignancy Trial in Boston (Home Transfusion Program Components)

    Not yet recruiting
    • Hematologic Malignancy
    • Home Transfusion Program Components
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Aug 18, 2022

    Cancer Survivorship in Hematologic Malignancies

    Not yet recruiting
    • Cancer Survivors
    • questionnaire
    • Assiut, Egypt
      Assiut University
    Mar 10, 2023